Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HOOK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TGFBR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EFCAB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHTF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHD1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPDL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SAR1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMMR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HP1BP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD3EAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OPA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929612 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHNO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AURKA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZWILCH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on